{{medical}}
{{Drugbox
| verifiedrevid = 458281479
| IUPAC_name = hydroxyurea
| image = Hydroxyurea.png
| width = 180
| alt = Structural formula
| image2 = Hydroxyurea-3D-balls.png

<!--Clinical data-->
| tradename =  Apo-Hydroxyurea, Droxia, Hydrea
| Drugs.com = {{drugs.com|international|hydroxycarbamide}}
| MedlinePlus = a682004
| pregnancy_category = D (USA)<ref name=Liebelt2007/>
| legal_status = Rx-only
| routes_of_administration = 口服

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism = [[肝脏|肝脏]]
| elimination_half-life = 3-4小时
| excretion = [[肾脏|肾脏]]与[[肺|肺]]

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 127-07-1
| ATC_prefix = L01
| ATC_suffix = XX05
| ATC_supplemental =  
| PubChem = 3657
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB01005
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3530
| NIAID_ChemDB = 006310
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = X6Q56QN5QC
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00341
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 44423
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 467

<!--Chemical data-->
| C=1 | H=4 | N=2 | O=2 
| molecular_weight = 76.0547 g/mol
| smiles = O=C(N)NO
| InChI = 1/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)
| InChIKey = VSNHCAURESNICA-UHFFFAOYAY
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VSNHCAURESNICA-UHFFFAOYSA-N
}}
'''羟基脲'''（[[国际非专利药品名称|INN]]：'''Hydroxycarbamide'''，又名'''Hydroxyurea'''，商品名包括'''Hydrea'''和'''Droxia'''）是一种[[化疗|化疗]]及[[抗逆转录病毒药物|抗逆转录病毒药物]]，被用于治疗[[慢性粒细胞白血病|慢性粒细胞白血病]]、[[骨髓增生性疾病|骨髓增生性疾病]]和[[镰刀型细胞贫血症|镰刀型细胞贫血症]]等疾病。

==作用机理==
羟基脲的其中一种普遍接受的机理是它能够通过清除酪氨酰[[自由基|自由基]]来抑制[[核糖核苷酸二磷酸还原酶|核糖核苷酸二磷酸还原酶]]，从而阻碍[[脱氧核糖核苷酸|脱氧核糖核苷酸]]的合成。<ref>{{DorlandsDict|four/000050608|hydroxyurea}}</ref><ref name=Platt2008>{{cite journal |author=Platt OS |title=Hydroxyurea for the treatment of sickle cell anemia |journal=N. Engl. J. Med. |volume=358 |issue=13 |pages=1362–9 |year=2008 |pmid=18367739 |doi=10.1056/NEJMct0708272}}</ref>

在镰刀型细胞贫血症的治疗中，羟基脲能够增加[[胎儿血红蛋白|胎儿血红蛋白]]的浓度。这点的具体作用机理仍不清楚，但有研究认为羟基脲能够增加[[一氧化氮|一氧化氮]]的浓度，从而激活[[鸟苷酸环化酶|鸟苷酸环化酶]]，进而增加[[环磷酸鸟苷|环磷酸鸟苷]]的浓度，激活胎儿血红蛋白所需的[[丙种球蛋白|丙种球蛋白]]的合成，同时清除快速分裂的产生镰刀型[[血红蛋白|血红蛋白]]的细胞。<ref name=Platt2008/><ref name="pmid12531879">{{cite journal |author=Cokic VP, Smith RD, Beleslin-Cokic BB, ''et al.'' |title=Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase |journal=J Clin Invest |volume=111 |issue=2 |pages=231–9 |year=2003 |pmid=12531879 |doi=10.1172/JCI16672|url=http://www.jci.org/articles/view/16672 |pmc=151872}} {{PMC|151872}}</ref>

==用途==
羟基脲被用于治疗以下疾病：
* 骨髓增生性疾病（主要是[[真性红细胞增多症|真性红细胞增多症]]和[[原发性血小板增多症|原发性血小板增多症]]）<ref name="pmid16000354">{{cite journal |author=Harrison CN, Campbell PJ, Buck G, ''et al.'' |title=Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia |journal=N. Engl. J. Med. |volume=353 |issue=1 |pages=33–45 |pmid=16000354 |doi=10.1056/NEJMoa043800 |url=http://content.nejm.org/cgi/pmidlookup?view=short&pmid=16000354&promo=ONFLNS19|date=July 2005}}</ref>
* 镰刀型细胞贫血症（能够减少发作时患者的疼痛）<ref name="pmid18458272">{{cite journal |author=Lanzkron S, Strouse JJ, Wilson R, ''et al.'' |title=Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease |journal=Ann. Intern. Med. |volume=148 |issue=12 |pages=939–55 |pmid=18458272 |doi= |url=|date=June 2008}}</ref>
* [[艾滋病|艾滋病]]（用于在抗[[逆转录病毒|逆转录病毒]]疗法辅助[[去羟肌苷|去羟肌苷]]）<ref name="pmid15597521">{{cite journal |author=Frank I, Bosch RJ, Fiscus S, ''et al.'' |title=Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307 |journal=AIDS Res. Hum. Retroviruses |volume=20 |issue=9 |pages=916–26 |pmid=15597521 |doi= 10.1089/aid.2004.20.916|url=|date=September 2004}}</ref>
* [[銀屑病|銀屑病]]的二线治疗（能够减缓[[皮肤细胞|皮肤细胞]]的快速分裂）<ref name="pmid17642550">{{cite journal |author=Sharma VK, Dutta B, Ramam M |title=Hydroxyurea as an alternative therapy for psoriasis |journal=Indian J Dermatol Venereol Leprol |volume=70 |issue=1 |pages=13–7 |year=2004 |pmid=17642550 |doi= |url=http://www.ijdvl.com/article.asp?issn=0378-6323;year=2004;volume=70;issue=1;spage=13;epage=17;aulast=Sharma}}</ref>
* [[肥大细胞增多症|肥大细胞增多症]]<ref>{{Cite journal | last1 = Escribano | first1 = L. | last2 = Álvarez-Twose | first2 = I. N. | last3 = Sánchez-Muñoz | first3 = L. | last4 = Garcia-Montero | first4 = A. | last5 = Núñez | first5 = R. | last6 = Almeida | first6 = J. | last7 = Jara-Acevedo | first7 = M. | last8 = Teodósio | first8 = C. | last9 = García-Cosío | first9 = M. N. | doi = 10.1016/j.jaci.2009.05.003 | title = Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients | journal = Journal of Allergy and Clinical Immunology | volume = 124 | issue = 3 | pages = 514–521 | year = 2009 | pmid = 19541349 | pmc = }}</ref>
*[[慢性粒细胞白血病|慢性粒细胞白血病]]（基本上被[[伊马替尼|伊马替尼]]所代替，但仍因其高性价比而被使用）<ref>{{Cite journal | last1 = Dalziel | first1 = K. | last2 = Round | first2 = A. | last3 = Stein | first3 = K. | last4 = Garside | first4 = R. | last5 = Price | first5 = A. | title = Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: A systematic review and economic analysis | journal = Health technology assessment (Winchester, England) | volume = 8 | issue = 28 | pages = iii, ii1–120 | year = 2004 | pmid = 15245690 }}</ref>
*[[头颈癌|头颈癌]]（单独给药或与[[放疗|放疗]]合用）
*[[卵巢癌|卵巢癌]]（同上）
除此之外，羟基脲还在[[生物化学|生物化学]]研究上被用作[[DNA复制|DNA复制]]抑制剂，因为它能够消耗脱氧核糖核苷酸而引起[[DNA|DNA]]双链在复制叉附近断裂（见[[DNA修复|DNA修复]]）。<ref name="pmid14573610">{{cite journal |author=Koç A, Wheeler LJ, Mathews CK, Merrill GF |title=Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools |journal=J. Biol. Chem. |volume=279 |issue=1 |pages=223–30 |pmid=14573610 |doi=10.1074/jbc.M303952200 |url=http://www.jbc.org/cgi/pmidlookup?view=long&pmid=14573610|date=January 2004}}</ref>

==剂量==
剂量因情况而异。在骨髓增生性疾病中，一般来说是每日30mg~40mg/kg；剂量的增加与减少由[[血细胞|血细胞]]计数变化及是否发生[[骨髓抑制|骨髓抑制]]而定。<ref name="gale" /> 对于镰刀型细胞贫血症，起始剂量为15mg/kg（[[肾功能|肾功能]]减弱者则酌情减少）；两周之后预期[[血红蛋白|血红蛋白]]和[[血小板|血小板]]计数将会减少，而[[平均红细胞|平均红细胞]]体积会增加。之后的剂量在密切观察[[全血细胞计数|全血细胞计数]]的同时每两周增加一次，直至剂量达到35mg/kg或血球减少发生。<ref name=Platt2008/>

==副作用==
有报导的[[副作用|副作用]]包括：[[嗜睡|嗜睡]]、[[恶心|恶心]]、[[呕吐|呕吐]]、[[腹泻|腹泻]]、[[便秘|便秘]]、[[食欲不振|食欲不振]]、[[粘膜炎|粘膜炎]]、[[胃炎|胃炎]]、[[骨髓抑制|骨髓抑制]]（剂量限制性毒性；停药后1~3周可恢复）、[[脱发|脱发]]、[[皮肤|皮肤]]变化、[[肝功能測試|肝功能]]异常、肾功能异常（[[肌酐|肌酐]]和[[尿氮|尿氮]]升高）。<ref name=Liebelt2007>{{Cite journal| doi = 10.1002/bdrb.20123| pmid = 17712860| year = 2007| last1 = Liebelt | first1 = E.| last2 = Balk | first2 = S.| last3 = Faber | first3 = W.| last4 = Fisher | first4 = J.| last5 = Hughes | first5 = C.| last6 = Lanzkron | first6 = S. | last7 = Lewis | first7 = K. | last8 = Marchetti | first8 = F.| last9 = Mehendale | first9 = H. | title = NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea | volume = 80 | issue = 4 | pages = 259–366 | journal = Birth defects research. Part B, Developmental and reproductive toxicology }}</ref>

由于羟基脲的[[骨髓|骨髓]]毒性，治疗时必须密切观察全血细胞计数，且应及时应对由于[[白细胞|白细胞]]水平下降而引起的感染。除此之外，肝肾功能、[[尿酸|尿酸]]和[[电解质|电解质]]也需经常检查。<ref name="gale">{{Cite book|last=Thackery |first=Ellen |title=The Gale Encyclopedia of Cancer: A-K |publisher=Thomson Gale |location=Detroit |year=2002 |page=514-516 |isbn=0-7876-5610-0}}</ref>

羟基脲主要用于治疗的骨髓增生性疾病大部分都有转化为[[急性粒细胞白血病|急性粒细胞白血病]]的可能性。长期以来人们一直担心羟基脲本身也会引起[[白血病|白血病]]，但研究显示这种可能性很小或者基本上不存在。然而，这仍然阻碍了它在镰刀型贫血症上的进一步应用。<ref name=Platt2008/>

==合成==
羟基脲由Dresler和Stein在1869年通过[[羟胺|羟胺]]、[[盐酸|盐酸]]和[[氰化钾|氰化钾]]反应合成；目前工业上生产则使用羟胺和[[氰酸|氰酸]]。<ref>{{cite journal | doi = 10.1016/S0950-4230(02)00044-X | title = Hydroxyurea explosion: a thermoanalytical and calorimetric study | year = 2002 | last1 = Lunghi | first1 = A | last2 = Aloni | first2 = C | last3 = Gigante | first3 = L | last4 = Mazzei | first4 = N | last5 = Cardillo | first5 = P | journal = Journal of Loss Prevention in the Process Industries | volume = 15 | issue = 6 | pages = 489–495 }}</ref>羟基脲也能由[[氨基甲酸乙酯|氨基甲酸乙酯]]与羟胺通过[[取代反应|取代反应]]合成。<ref>{{OrgSynth | author = R. Deghenghi | collvol = 5 | collvolpages = 645 | prep = cv5p0645 | year = 1973 | title = Hydroxyurea}}</ref>

由氰酸鈉和羟胺作用合成羟基脲須利用離子交換樹脂。化學式如下：

<center>NaOCN + NH<sub>2</sub>OH → 羟基脲</center>

==参考资料==
{{reflist|2}}

{{-}}
{{化疗药物}}
{{抗逆转录病毒药物}}

[[Category:脲|Category:脲]]
[[Category:抗肿瘤抗代谢物|Category:抗肿瘤抗代谢物]]
[[Category:IARC第3类致癌物质|Category:IARC第3类致癌物质]]